COPD Trial, Recruiting NCT06974981 Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06974981
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 50 and 80 years old
  • You are a current or former smoker with at least 20 "pack-years" of smoking history (for example, one pack per day for 20 years, or two packs per day for 10 years)
  • You are willing to take part in an observational study and be contacted about possible future related studies, which may include treatment trials
  • You are able to tolerate the study procedures involved
  • You are able to understand and sign a consent form
  • You have had a lung cancer screening CT scan at the University of Michigan within the past year
  • You meet at least one of these three conditions: you have been diagnosed with COPD (a chronic lung disease), your breathing test results have shown signs of COPD, or your recent CT scan showed signs of air trapping in the lungs (confirm with trial site)

Who may not be able to join:

  • You have a serious breathing condition other than COPD or asthma that may be the main cause of your breathing symptoms
  • You have severe asthma, meaning you are on high-level asthma medications, have had 3 or more unplanned medical visits for asthma in the past year, or have been hospitalised for asthma in the past year (confirm with trial site)
  • You are currently taking part in another clinical trial where the treatment is kept secret (blinded)
  • You are currently pregnant; women who could become pregnant will need to provide documentation of birth control
  • You have a cognitive (thinking or memory) difficulty that would prevent you from completing study activities
  • Your body mass index (BMI) is above 35, as body weight can affect the quality of the CT scan images
  • You currently use illegal substances, including smoking cannabis
  • You have a serious illness that is expected to be life-limiting within the next 3 years
  • You have any metal implants or devices in your upper body that could interfere with CT scan quality
  • You have a history of radiation therapy or surgery to the chest where lung tissue was removed
  • You have had a COPD flare-up in the last 30 days, but you may be able to re-apply once 30 days have passed since finishing any treatment for it
  • You are currently taking a short-term course of antibiotics or steroids, but you may be able to re-apply 30 or more days after finishing them (note: this does not apply if you take low-dose steroids or antibiotics regularly on a long-term basis — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Julie Barta, MD, ATSF, Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Phone: 215-955-5161

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Registry
ClinicalTrials.gov
Start date
2 January 2025
Est. completion
30 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

COPD diagnosis based on meeting spirometric criteria; Accrual rate; Intervention compliance rate; Follow-up retention rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov